Stereotaxis, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Stereotaxis, Inc. on July 30, 2010. The filing reports the entry into a material definitive agreement with Biosense Webster, Inc.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a contractual amendment rather than periodic financial results.
Material Changes and Agreement Details
On July 30, 2010, the Company entered into a Fifth Amendment to the Development Alliance and Supply Agreement with Biosense Webster. Key provisions include:
- Extension of Biosense Webster's exclusive distribution rights for non-irrigated catheters until December 31, 2010.
- Support for pursuing U.S. FDA regulatory approval to expand indications for magnetically enabled devices for atrial fibrillation (AF).
- Development of improvements to certain devices or design of next-generation magnetically enabled irrigated catheters, subject to a future written agreement.
- Exploration of remote clinical support applications for the Odyssey platform and potential extension of non-exclusive Odyssey license rights to include distribution as a consolidated solution with CARTO products.
- Updates to the revenue sharing arrangement to reflect the extension of terms.
Guidance, Outlook, and Risks
The filing does not contain specific financial guidance or management commentary on future performance. The agreement outlines strategic development goals, including regulatory approvals and product design, which are contingent upon the execution of further written agreements between the parties.
Investor Verification Checklist
- Verify the specific terms of the updated revenue sharing arrangement.
- Monitor progress on the FDA regulatory approval for expanded atrial fibrillation indications.
- Confirm the execution of any subsequent written agreements required for next-generation catheter design or Odyssey platform expansion.
- Review the full text of the Fifth Amendment filed as Exhibit 10.1 for detailed legal obligations.